ArticleJournal of gastrointestinal cancer2025
The Efficacy and Safety of Nivolumab Combined with Nab-Paclitaxel or Oxaliplatin as a First-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer.
Juan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.